Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

5.62
Delayed Data
As of Jun 24
 -0.26 / -4.42%
Today’s Change
4.25
Today|||52-Week Range
26.80
-35.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$226.0M

Company Description

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio focuses on oncology and chronic cancer pain treatment. Its drugs include immuno-oncology antibodies, cellular therapy, biosimilars, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry Ji in 2006 and is headquartered in San Diego, CA.

Contact Information

Sorrento Therapeutics, Inc.
9380 Judicial Drive
San Diego California 92121
P:(858) 210-3700
Investor Relations:

Employees

Shareholders

Individual stakeholders40.28%
Other institutional24.16%
Mutual fund holders10.03%

Top Executives

Henry H. JiPresident, Chief Executive Officer & Director
Jeffrey SuChief Operating Officer & Executive Vice President
Kevin M. HerdeChief Financial Officer & Executive Vice President
Zhenwei MiaoChief Technology Officer
George K. NgChief Administrative Officer & Executive VP